Signaling Pathways - Androgen Receptors - Hydroxylases - SUMOylation - Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
清除全部
-
A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂 -
B4751 L-MimosineTarget: HydroxylasesSummary: 铁螯合剂和脯氨酰-4-羟化酶抑制剂 -
B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂 -
B1036 MLN49245 CitationTarget: NAE|Ubiquitin-activating Enzyme E1|SUMOylationSummary: NAE抑制剂 -
A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体（AR）拮抗剂 -
A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂 -
A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体（Androgen receptor）拮抗剂 -
A4506 DMOGTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: 细胞通透的竞争性HIF-PH抑制剂 -
A4335 Mildronate中文名: 米屈肼Target: Hydroxylases|carnitine reabsorptionSummary: GBB羟化酶抑制剂 -
A3003 MDV3100 (Enzalutamide)12 Citation中文名: 恩杂鲁胺Target: Androgen ReceptorsSummary: 雄激素受体拮抗剂。